Vol 77, No 3 (2018)
Case report
Published online: 2017-12-28

open access

Page views 1291
Article views/downloads 1139
Get Citation

Connect on Social Media

Connect on Social Media

Giant cardiac tumours in the newborn: an unusual image

J. Kwiatkowska1, S. Ciemny1, D. Kozłowski2
Pubmed: 29297180
Folia Morphol 2018;77(3):601-603.

Abstract

Primary heart tumours in the paediatric population are very rare and they range from 0.01% to 0.04%. Most are benign lesions of which about half are rhabdomyomas. Rhabdomyoma tumour diagnosis is associated with a 75–80% risk of tuberous sclerosis complex (TSC). TSC are characterised with numerous changes of hamartoma-type located in the brain, kidneys, skin and other organs including the heart. More than two-thirds of newborns with TSC present rhabdomyomas in the heart. These changes may be asymptomatic, but in some cases they may cause heart failure, arrhythmias and death. We present a case report of an infant with giant rhabdomyoma tumours in the course of TSC.

Article available in PDF format

View PDF Download PDF file

References

  1. Becker AE. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol. 2000; 21(4): 317–323.
  2. Beghetti M, Gow RM, Haney I, et al. Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J. 1997; 134(6): 1107–1114.
  3. Freedom RM, Lee KJ, MacDonald C, et al. Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol. 2000; 21(4): 299–316.
  4. Gibbs JL. The heart and tuberous sclerosis. An echocardiographic and electrocardiographic study. Br Heart J. 1985; 54(6): 596–599.
  5. Hinton RB, Prakash A, Romp RL, et al. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. J Am Heart Assoc. 2014; 3(6): e001493.
  6. Kwiatkowska J, Wałdoch A, Meyer-Szary J, et al. Cardiac tumors in children: A 20-year review of clinical presentation, diagnostics and treatment. Adv Clin Exp Med. 2017; 26(2): 319–326.
  7. Linnemeier L, Benneyworth BD, Turrentine M, et al. Pediatric cardiac tumors: a 45-year, single-institution review. World J Pediatr Congenit Heart Surg. 2015; 6(2): 215–219.
  8. Mlczoch E, Hanslik A, Luckner D, et al. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus. Ultrasound Obstet Gynecol. 2015; 45(5): 618–621.
  9. Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4): 243–254.
  10. Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996; 77(1): 107.
  11. Sciacca P, Giacchi V, Mattia C, et al. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases. BMC Cardiovasc Disord. 2014; 14: 66.
  12. Song Y, Yao Q, Liu C, et al. Morphological observations of tumors in cardiac conduction system. J Geriatric Cardiol September. 2007; 4: 164–167.
  13. Tiberio D, Franz DN, Phillips JR. Regression of a cardiac rhabdomyoma in a patient receiving everolimus. Pediatrics. 2011; 127(5): e1335–e1337.
  14. Tworetzky W, McElhinney DB, Margossian R, et al. Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol. 2003; 92(4): 487–489.
  15. Uzun O, Wilson DG, Vujanic GM, et al. Cardiac tumours in children. Orphanet J Rare Dis. 2007; 2: 11.